Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VAL-083 in Recurrent Malignant Glioma
NCT01478178Phase 2Completed
- Sponsor
- Kintara Therapeutics
- Start
- Oct 2011
- Primary completion
- Dec 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of dianhydrogalactitol in malignant glioma, brain metastases, sponsored by Kintara Therapeutics. Started Oct 2011; status: completed.
02
Drugs
dianhydrogalactitol
03
Conditions
malignant gliomabrain metastases
Beyond the preview
Go deeper on NCT01478178.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01478178.